Cargando…

Cognitive Behavioral Therapy for People with Chronic Obstructive Pulmonary Disease: Rapid Review

Cognitive behavioral therapy (CBT) is increasingly recommended in the management of people living with chronic obstructive pulmonary disease (COPD). This rapid review presents the evidence base for CBT for people with COPD and describes 1) the nature of CBT interventions and comparators in controlle...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Marie T, Johnston, Kylie N, Paquet, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186773/
https://www.ncbi.nlm.nih.gov/pubmed/32425516
http://dx.doi.org/10.2147/COPD.S178049
_version_ 1783527026590744576
author Williams, Marie T
Johnston, Kylie N
Paquet, Catherine
author_facet Williams, Marie T
Johnston, Kylie N
Paquet, Catherine
author_sort Williams, Marie T
collection PubMed
description Cognitive behavioral therapy (CBT) is increasingly recommended in the management of people living with chronic obstructive pulmonary disease (COPD). This rapid review presents the evidence base for CBT for people with COPD and describes 1) the nature of CBT interventions and comparators in controlled trials (high or low resource intensity); and 2) factors influencing intervention effects on health outcomes (anxiety, depression, breathlessness, quality of life and exercise capacity). Primary studies reporting CBT interventions in adults with COPD were identified with data extracted by a single reviewer (20% of studies checked for data accuracy). Studies were synthesized descriptively with meta-analyses (random effects models) of controlled trials undertaken to report mean standardized effect sizes (95% CI) for health outcomes. Random effects meta-regression models explored whether CBT target, intervention dosage, intensity, facilitator profession, delivery mode, clinically significant anxiety/depression, trial design/quality and sample size predicted effect size. The search identified 33 primary studies published between 1996 and 2019 (controlled trials n=24, single group cohort n=6, case exemplars n=2, phenomenological n=1). Controlled trials frequently compared high-intensity CBT interventions against enhanced/usual care (n=12) or high-intensity CBT interventions against high-intensity comparators (n=11). When all controlled studies were included, small, significant improvements favoring CBT were evident across all health outcomes (SMD ranged from −0.27 to 0.35, p<0.05). When intensity dyads were considered, significant improvements were evident only when high-intensity CBT interventions were compared to enhanced usual care/usual care (SMDs ranged from −0.45 to 0.54, p <0.05). No other variable consistently predicted intervention effect sizes across all health outcomes. Overall, the evidence base supports the use of CBT for a range of health outcomes in people with COPD. Consistent benefits were evident when high-resource-intensive CBT interventions were compared to usual care. Low-resource-intensity CBT warrants further investigation in settings where cost of comprehensive care is prohibitive.
format Online
Article
Text
id pubmed-7186773
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-71867732020-05-18 Cognitive Behavioral Therapy for People with Chronic Obstructive Pulmonary Disease: Rapid Review Williams, Marie T Johnston, Kylie N Paquet, Catherine Int J Chron Obstruct Pulmon Dis Review Cognitive behavioral therapy (CBT) is increasingly recommended in the management of people living with chronic obstructive pulmonary disease (COPD). This rapid review presents the evidence base for CBT for people with COPD and describes 1) the nature of CBT interventions and comparators in controlled trials (high or low resource intensity); and 2) factors influencing intervention effects on health outcomes (anxiety, depression, breathlessness, quality of life and exercise capacity). Primary studies reporting CBT interventions in adults with COPD were identified with data extracted by a single reviewer (20% of studies checked for data accuracy). Studies were synthesized descriptively with meta-analyses (random effects models) of controlled trials undertaken to report mean standardized effect sizes (95% CI) for health outcomes. Random effects meta-regression models explored whether CBT target, intervention dosage, intensity, facilitator profession, delivery mode, clinically significant anxiety/depression, trial design/quality and sample size predicted effect size. The search identified 33 primary studies published between 1996 and 2019 (controlled trials n=24, single group cohort n=6, case exemplars n=2, phenomenological n=1). Controlled trials frequently compared high-intensity CBT interventions against enhanced/usual care (n=12) or high-intensity CBT interventions against high-intensity comparators (n=11). When all controlled studies were included, small, significant improvements favoring CBT were evident across all health outcomes (SMD ranged from −0.27 to 0.35, p<0.05). When intensity dyads were considered, significant improvements were evident only when high-intensity CBT interventions were compared to enhanced usual care/usual care (SMDs ranged from −0.45 to 0.54, p <0.05). No other variable consistently predicted intervention effect sizes across all health outcomes. Overall, the evidence base supports the use of CBT for a range of health outcomes in people with COPD. Consistent benefits were evident when high-resource-intensive CBT interventions were compared to usual care. Low-resource-intensity CBT warrants further investigation in settings where cost of comprehensive care is prohibitive. Dove 2020-04-23 /pmc/articles/PMC7186773/ /pubmed/32425516 http://dx.doi.org/10.2147/COPD.S178049 Text en © 2020 Williams et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Williams, Marie T
Johnston, Kylie N
Paquet, Catherine
Cognitive Behavioral Therapy for People with Chronic Obstructive Pulmonary Disease: Rapid Review
title Cognitive Behavioral Therapy for People with Chronic Obstructive Pulmonary Disease: Rapid Review
title_full Cognitive Behavioral Therapy for People with Chronic Obstructive Pulmonary Disease: Rapid Review
title_fullStr Cognitive Behavioral Therapy for People with Chronic Obstructive Pulmonary Disease: Rapid Review
title_full_unstemmed Cognitive Behavioral Therapy for People with Chronic Obstructive Pulmonary Disease: Rapid Review
title_short Cognitive Behavioral Therapy for People with Chronic Obstructive Pulmonary Disease: Rapid Review
title_sort cognitive behavioral therapy for people with chronic obstructive pulmonary disease: rapid review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186773/
https://www.ncbi.nlm.nih.gov/pubmed/32425516
http://dx.doi.org/10.2147/COPD.S178049
work_keys_str_mv AT williamsmariet cognitivebehavioraltherapyforpeoplewithchronicobstructivepulmonarydiseaserapidreview
AT johnstonkylien cognitivebehavioraltherapyforpeoplewithchronicobstructivepulmonarydiseaserapidreview
AT paquetcatherine cognitivebehavioraltherapyforpeoplewithchronicobstructivepulmonarydiseaserapidreview